Wai Chun Bio-Technology Limited (HKG:0660)

Market Cap	158.09M +433.6%
Revenue (ttm)	568.26M +66.7%
Net Income	-6.90M
EPS	-0.04
Shares Out	367.64M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	100,000
Open	0.4300
Previous Close	0.4300
Day's Range	0.4050 - 0.4300
52-Week Range	0.1600 - 2.3300
Beta	1.29
Analysts	n/a
Price Target	n/a
Earnings Date	Sep 30, 2026

About Wai Chun Bio-Technology

Wai Chun Bio-Technology Limited, an investment holding company, engages in the manufacture and sale of modified starch and other biochemical products in the People’s Republic of China. The company was formerly known as Wai Chun Mining Industry Group Company Limited and changed its name to Wai Chun Bio-Technology Limited in September 2019. The company was incorporated in 1992 and is headquartered in Wan Chai, Hong Kong.

• Industry: Chemicals
• Sector: Materials
• Founded: 1992
• Employees: 63
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 0660

Financial Performance

In fiscal year 2025, Wai Chun Bio-Technology's revenue was 377.17 million, an increase of 1.92% compared to the previous year's 370.07 million. Losses were -14.62 million, -66.93% less than in 2024.

Data Sources: S&P Global Market Intelligence and Financial Modeling Prep

Fundamental and historical data is provided by S&P Global Market Intelligence. Delayed stock pricing data is provided by Financial Modeling Prep.

Last checked:

Oct 8, 2026

Data Sources Report a data error